Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity.
Journal: Science advances
Published: May 06, 2026
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.
Journal: Nature cancer
Published: January 17, 2025
The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer.
Journal: Cancer research
Published: October 25, 2024
Fibroblastic FLT3L supports lymph node dendritic cells in the interfollicular niche.
Journal: Nature immunology
Published: July 26, 2024
Veterans Health Administration response to 2021 recall of Philips Respironics devices: A case study.
Veterans Health Administration response to 2021 recall of Philips Respironics devices: A case study.
Journal: Frontiers in sleep
Published: April 08, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.
Journal: Nature cancer
Published: April 01, 2024
The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.
Journal: Cancer immunology research
Published: December 19, 2023
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control.
Journal: Nature
Published: October 04, 2023
Sustainment of the TeleSleep program for rural veterans.
Journal: Frontiers in health services
Published: April 28, 2023
Last Updated: 09/26/2026